EvidentIQ Germany Awarded Platinum Pharma Supplier Certification by Qualifyze
We are thrilled to announce that EvidentIQ Germany has been recognized as a Platinum Pharma Supplier by Qualifyze’s quality compliance program as of May 14, 2024. This
Press Releases
Happy 10th! EvidentIQ Germany, formerly known as XClinical, is proud to mark a decade of fruitful collaboration with Cardialysis, a renowned CRO & Core Laboratory!
For the past ten years, EvidentIQ Germany and Cardialysis have joined forces to achieve impressive accomplishments in clinical research. Together, they have enrolled over 46,000 participants in 56 studies spanning various therapeutic areas and study phases, with a primary focus on cardiology.
EvidentIQ is pleased to announce the addition of Asthenis GmbH to their comprehensive eClinical solutions group.
We are proud to announce the acquisition of Asthenis GmbH, the market leader in cancer documentation software in the DACH region (Germany, Austria and Switzerland).
Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies
EvidentIQ, the innovative provider of advanced clinical trial management solutions has joined forces with Quinta Analytica, a renowned GCP/GLP/GMP-certified European CRO and part of the
Carenity, part of the EvidentIQ Group, announces change in leadership
Carenity, a prominent patient-centric company and member of the EvidentIQ Group, announces a change in its leadership. Michael Chekroun, founder of Carenity and outgoing President, will be
EvidentIQ helps clients streamline their Metadata management process
EvidentIQ launches a new Managed Service Model that not only supports the use of the open-source solution OpenStudyBuilder, but also helps clients customizing it to
